| 000 | 01781 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514022808.0 | ||
| 264 | 0 | _c20020320 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0014-2980 | ||
| 024 | 7 |
_a10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobinson, Stephen C | |
| 245 | 0 | 0 |
_aChemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _c02 2002 |
||
| 300 |
_a404-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Movement _xphysiology |
| 650 | 0 | 4 |
_aChemokine CCL2 _xpharmacology |
| 650 | 0 | 4 | _aChemokine CCL3 |
| 650 | 0 | 4 | _aChemokine CCL4 |
| 650 | 0 | 4 |
_aChemokine CCL5 _xpharmacology |
| 650 | 0 | 4 |
_aChemokines, CC _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLeukocytes _xphysiology |
| 650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xpharmacology |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aScott, Kate A | |
| 700 | 1 | _aBalkwill, Frances R | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 32 _gno. 2 _gp. 404-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X _zAvailable from publisher's website |
| 999 |
_c11723523 _d11723523 |
||